AF10 regulates progressive H3K79 methylation and HOX gene expression in diverse AML subtypes.

[1]  Robert A Copeland,et al.  Potent inhibition of DOT1L as treatment of MLL-fusion leukemia. , 2013, Blood.

[2]  O. Bernard,et al.  Identification of GSX2 and AF10 as NUP98 partner genes in myeloid malignancies , 2013, Blood Cancer Journal.

[3]  S. Hoersch,et al.  The ZFP-1(AF10)/DOT-1 complex opposes H2B ubiquitination to reduce Pol II transcription. , 2013, Molecular cell.

[4]  C. Mecucci,et al.  New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia. , 2013, Blood.

[5]  S. Armstrong,et al.  Abrogation of MLL–AF10 and CALM–AF10-mediated transformation through genetic inactivation or pharmacological inhibition of the H3K79 methyltransferase Dot1l , 2013, Leukemia.

[6]  S. Armstrong,et al.  Leukemic transformation by the MLL-AF6 fusion oncogene requires the H3K79 methyltransferase Dot1l. , 2013, Blood.

[7]  K. Wagner,et al.  Analysis of NUP98/NSD1 translocations in adult AML and MDS patients , 2013, Leukemia.

[8]  J. Arredondo,et al.  AF10 Plays a Key Role in the Survival of Uncommitted Hematopoietic Cells , 2012, PloS one.

[9]  P. Atadja,et al.  Selective inhibition of Ezh2 by a small molecule inhibitor blocks tumor cells proliferation , 2012, Proceedings of the National Academy of Sciences.

[10]  Tim J. Wigle,et al.  A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells. , 2012, Nature chemical biology.

[11]  S. Armstrong,et al.  Chromatin modifications as therapeutic targets in MLL-rearranged leukemia. , 2012, Trends in immunology.

[12]  Yan Liu,et al.  EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations , 2012, Nature.

[13]  Scott A. Armstrong,et al.  iCanPlot: Visual Exploration of High-Throughput Omics Data Using Interactive Canvas Plotting , 2012, PloS one.

[14]  Yong Jiang,et al.  Mutation of A677 in histone methyltransferase EZH2 in human B-cell lymphoma promotes hypertrimethylation of histone H3 on lysine 27 (H3K27) , 2012, Proceedings of the National Academy of Sciences.

[15]  Kiran C. Bobba,et al.  The genetic basis of early T-cell precursor acute lymphoblastic leukaemia , 2012, Nature.

[16]  R. Pieters,et al.  NUP98/NSD1 characterizes a novel poor prognostic group in acute myeloid leukemia with a distinct HOX gene expression pattern. , 2011, Blood.

[17]  Lars Bullinger,et al.  MLL-rearranged leukemia is dependent on aberrant H3K79 methylation by DOT1L. , 2011, Cancer cell.

[18]  Yonghong Xiao,et al.  Selective killing of mixed lineage leukemia cells by a potent small-molecule DOT1L inhibitor. , 2011, Cancer cell.

[19]  Yi Zhang,et al.  The diverse functions of Dot1 and H3K79 methylation. , 2011, Genes & development.

[20]  Yi Zhang,et al.  DOT1L, the H3K79 methyltransferase, is required for MLL-AF9-mediated leukemogenesis. , 2011, Blood.

[21]  Dafydd G. Thomas,et al.  Requirement for Dot1l in murine postnatal hematopoiesis and leukemogenesis by MLL translocation. , 2011, Blood.

[22]  L. Staudt,et al.  The MMSET histone methyl transferase switches global histone methylation and alters gene expression in t(4;14) multiple myeloma cells. , 2011, Blood.

[23]  N. Zeleznik-Le,et al.  Histone H3 lysine 79 methyltransferase Dot1 is required for immortalization by MLL oncogenes. , 2010, Cancer research.

[24]  R. Copeland,et al.  Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomas , 2010, Proceedings of the National Academy of Sciences.

[25]  Junjie Chen,et al.  Characterization of the DOT1L Network: Implications of Diverse Roles for DOT1L , 2010, The protein journal.

[26]  A. Shilatifard,et al.  Linking H3K79 trimethylation to Wnt signaling through a novel Dot1-containing complex (DotCom). , 2010, Genes & development.

[27]  C. Bach,et al.  Misguided Transcriptional Elongation Causes Mixed Lineage Leukemia , 2009, PLoS biology.

[28]  Jonghwan Kim,et al.  Use of in vivo biotinylation to study protein–protein and protein–DNA interactions in mouse embryonic stem cells , 2009, Nature Protocols.

[29]  Christopher R. Vakoc,et al.  DOT1L/KMT4 Recruitment and H3K79 Methylation Are Ubiquitously Coupled with Gene Transcription in Mammalian Cells , 2008, Molecular and Cellular Biology.

[30]  Scott A. Armstrong,et al.  MLL translocations, histone modifications and leukaemia stem-cell development , 2007, Nature Reviews Cancer.

[31]  R. Humphries,et al.  Hox genes in hematopoiesis and leukemogenesis , 2007, Oncogene.

[32]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[33]  M. Cleary,et al.  Identification and characterization of leukemia stem cells in murine MLL-AF9 acute myeloid leukemia. , 2006, Cancer cell.

[34]  T. Golub,et al.  Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9 , 2006, Nature.

[35]  Thomas A Milne,et al.  Regulation of MLL1 H3K4 methyltransferase activity by its core components , 2006, Nature Structural &Molecular Biology.

[36]  D. Grier,et al.  HOX GENES: Seductive Science, Mysterious Mechanisms , 2006, The Ulster medical journal.

[37]  Thomas A. Milne,et al.  WDR5 Associates with Histone H3 Methylated at K4 and Is Essential for H3 K4 Methylation and Vertebrate Development , 2005, Cell.

[38]  V. Honti,et al.  Characterization of the grappa Gene, the Drosophila Histone H3 Lysine 79 Methyltransferase , 2005, Genetics.

[39]  Kristian Helin,et al.  Suz12 is essential for mouse development and for EZH2 histone methyltransferase activity , 2004, The EMBO journal.

[40]  C. Ferraz,et al.  The Leucine Zipper Motif of the Drosophila AF10 Homologue Can Inhibit PRE-Mediated Repression: Implications for Leukemogenic Activity of Human MLL-AF10 Fusions , 2003, Molecular and Cellular Biology.

[41]  R. Newman,et al.  Biochemical analyses of the AF10 protein: the extended LAP/PHD-finger mediates oligomerisation. , 2000, Journal of molecular biology.

[42]  J. Rowley,et al.  The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  T. Haferlach,et al.  A rare but specific subset of adult AML patients can be defined by the cytogenetically cryptic NUP98–NSD1 fusion gene , 2013, Leukemia.

[44]  C. Buske,et al.  Abrogation of MLL – AF 10 and CALM – AF 10-mediated transformation through genetic inactivation or pharmacological inhibition of the H 3 K 79 methyltransferase Dot 1 l , 2012 .